Apr 10, 2026 05:39AM Mizuho Starts GRAIL, Inc. (GRAL) at Neutral

Apr 10, 2026 04:00AM Piper Sandler Starts GRAIL, Inc. (GRAL) at Neutral

Apr 7, 2026 04:01PM GRAIL integrates Galleri test into Epic health record platform

Apr 1, 2026 01:10PM Superpower partners with GRAIL to offer multi-cancer blood test

Mar 23, 2026 06:41AM Guggenheim Reiterates Buy Rating on GRAIL, Inc. (GRAL)

Mar 18, 2026 06:00AM TD Cowen Upgrades GRAIL, Inc. (GRAL) to Buy

Feb 23, 2026 05:23AM GRAIL, Inc. (GRAL) call put ratio 1.2 calls to 1 put amid wide price movement

Feb 20, 2026 09:18AM TD Cowen on GRAIL, Inc. (GRAL): 'Study Failure A Major Setback'

Feb 20, 2026 07:57AM GRAIL, Inc. (GRAL) PT Lowered to $80 at Canaccord Genuity

Feb 19, 2026 04:34PM After-hours movers: Akamai, Opendoor, GRAIL and more

Feb 19, 2026 04:05PM GRAIL, Inc. (GRAL) Tops Q4 EPS by 157c

Feb 19, 2026 04:02PM GRAIL cancer screening test reduces stage IV diagnoses in NHS trial

Feb 19, 2026 05:42AM TD Cowen Starts GRAIL, Inc. (GRAL) at Hold

Feb 17, 2026 03:35AM Baird Starts GRAIL, Inc. (GRAL) at Outperform

Jan 26, 2026 06:25AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)

Jan 14, 2026 06:34AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)

Jan 13, 2026 06:25AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)

Nov 17, 2025 06:41AM GRAIL, Inc. (GRAL) PT Raised to $105 at Canaccord Genuity

Nov 14, 2025 06:24AM GRAIL establishes $300 million at-the-market stock offering program

Nov 13, 2025 04:33PM GRAIL, Inc. (GRAL) files mixed shelf

Nov 12, 2025 04:35PM GRAIL, Inc. (GRAL) Tops Q3 EPS by 153c

Nov 12, 2025 06:45AM Guggenheim Upgrades GRAIL, Inc. (GRAL) to Buy

Oct 22, 2025 06:23AM GRAIL, Inc. (GRAL) PT Raised to $85 at Canaccord Genuity

Oct 20, 2025 11:42AM Hims & Hers CEO Dudum comments on Grail investment

Oct 20, 2025 06:01AM GRAIL study shows cancer test positive predictive value rises to 84.2%

Sep 23, 2025 09:04AM GRAIL to present data from 32,000 participants at medical conferences

Aug 12, 2025 04:03PM GRAIL, Inc. (GRAL) Tops Q2 EPS by 94c

Jun 25, 2025 04:07PM GRAIL, Inc. (GRAL) PT Raised to $38 at Morgan Stanley

Jun 18, 2025 09:01AM GRAIL, Inc. (GRAL) Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study

Jun 9, 2025 10:25AM GRAIL, Inc. (GRAL) Mentioned as Short at Ningi Research

May 14, 2025 10:23AM Increasing unusual put option volume: FND AEO FL CF EXEL TAN SATS ARCC NEXT GRAL NMM URA

May 14, 2025 04:32AM GRAIL, Inc. (GRAL) PT Raised to $43 at Canaccord Genuity, 'We believe the shares do not reflect the company's growth potential'

May 13, 2025 04:56PM After-hours movers: American Eagle Outfitters, Aurora, GRAIL

May 13, 2025 04:03PM GRAIL, Inc. (GRAL) Tops Q1 EPS by $1.16

May 12, 2025 04:01PM GRAIL (GRAL) and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

Apr 21, 2025 06:22AM Canaccord Genuity Starts GRAIL, Inc. (GRAL) at Buy

Feb 25, 2025 09:12AM GRAIL, Inc. (GRAL) partners with Kate Walsh to launch Generation Possible

Feb 20, 2025 04:25PM GRAIL, Inc. (GRAL) Reports Q4 Loss of $2.89

Nov 27, 2024 03:59AM Morgan Stanley Starts GRAIL, Inc. (GRAL) at Equalweight

Nov 12, 2024 04:33PM GRAIL, Inc. (GRAL) Reports Q3 Loss of $3.94

Oct 21, 2024 04:01PM GRAIL (GRAL) Appoints Sarah Krevans to its Board

Aug 29, 2024 04:17PM GRAIL, Inc. (GRAL): Results of Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

Aug 13, 2024 04:11PM GRAIL, Inc. (GRAL) Reports Q2 Loss of $51.06/sh

Jun 24, 2024 04:06PM GRAIL (GRAL) to Commence Separate Trading on Nasdaq